<?xml version="1.0" encoding="UTF-8"?>
<p id="Par25">The existence of chronic HEV infection was first reported in 2008 among solid organ transplant patients [
 <xref ref-type="bibr" rid="CR45">45</xref>]. Chronic HEV infection is seen clinically in immunosuppressed patients especially with defective T cell response arm, including patients on immunosuppressant for organ transplants, HIV, and hematological malignancies [
 <xref ref-type="bibr" rid="CR45">45</xref>–
 <xref ref-type="bibr" rid="CR47">47</xref>]. Chronic HEV infection is defined as the detection of HEV RNA in blood or stools or any other body fluids for more than 6 months [
 <xref ref-type="bibr" rid="CR11">11</xref>••]. Nearly, 10% of immunosuppressed chronic HEV-infected patients developed fibrosis and chronic liver disease within a few years [
 <xref ref-type="bibr" rid="CR48">48</xref>, 
 <xref ref-type="bibr" rid="CR49">49</xref>]. Recently, a case of hepatocellular carcinoma in a patient with HEV-associated cirrhosis has been described [
 <xref ref-type="bibr" rid="CR50">50</xref>•].
</p>
